KANSAS CITY, MO. — CRB announced Aug. 2 that Ryan Schroeder, president and chief executive officer, has retired from his role. Lee Emel, vice president of regional operations at CRB, will lead the company as interim president and CEO as it embarks upon the search for a permanent replacement.
“We owe Ryan Schroeder an enormous debt of gratitude for his more than 30 years of service to CRB,” said Jeff Biskup, founder of CRB and executive chairman of its board of directors. “On behalf of the entire CRB team, I wish to thank him for his many contributions to our organization.”
“Very few people get to start and finish their career with the same company,” Schroder added. “I’m one of those fortunate few. I began my journey at CRB as a design engineer straight out of college, and now over 36 years later I’m humbled to close this chapter as president and CEO. CRB is a special place and I’ll always bleed the culture and spirit that embodies our people. I am thrilled that Lee Emel has agreed to guide the company during this transition, and we could not be in better hands. He’s truly a visionary and inspirational leader.”
Lee Emel will serve as interim president and CEO until CRB finds a permanent replacement.
| Source: CRBEmel has nearly three decades of industry experience.
“Lee is a thought leader in the biotech and pharmaceutical industry,” Biskup said. “He has demonstrated that he has the leadership skills and experience to ensure that CRB continues as a premier provider to our clients and position us for long-term success in the future.”
Emel added, “I am honored to take on the role of CEO and lead our company into its next chapter. Over the past 25 years, it has been my privilege to be part of CRB’s growth — working side-by-side with some of the best AEC professionals in our industry.”
To support its search for a new president and CEO, CRB has retained an executive search firm.
Read more about personnel changes throughout the industry.
